// App-Quantinova.ai

10066 : CELF4 variant and Anthracycline-related Cardiomyopathy (anth-card) A COG Study (ALTE03N1).

Researchers

Presenter

  • Xuexia Wang

Principal Investigators

  • Adolfo Quinones Lombrana

  • Joseph Philip Neglia

  • Kevin C. Oeffinger

  • Sharon M. Castellino

  • Zo Ann Eckert Dreyer

  • Melissa M. Hudson

  • Leslie L. Robison

  • Javier G. Blanco

  • Lindsey Hageman

  • Molly Mather

  • Lu Chen

  • Saro Armenian

  • Naomi J. Winick

  • Jill P. Ginsberg

  • Smita Bhatia

  • Purnima Singh

  • Wendy Landier

Medical Centers

  • Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY

  • Texas Childrens Hospital, Houston, TX

  • Children's Oncology Group, Monrovia, CA

  • University of Wisconsin-Milwaukee, Milwaukee, WIMemorial Sloan Kettering Cancer Center, New York, NYUniversity of Minnesota, Minneapolis, MN

  • City of Hope National Medical Center, Duarte, CA

  • Childrens Hospital of Philadelphia, Philadelphia, PA

  • University of Alabama at Birmingham, Birmingham, AL

  • St. Jude Children's Research Hospital, Memphis, TN

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Wake Forest University, Winston-Salem, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mismatch repair deficiency

  • Heart muscle disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A